相关实验视频

Updated: Jun 19, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

NAMPT基因 rs2058539 变体是非酒精性脂肪肝疾病的危险因素

Shadi Nouri¹, Mahsa Navari², Fatemeh Zarei³

¹Arak University of Medical Sciences, School of Medicine, Department of Radiology - Arak, Iran.

Revista da Associacao Medica Brasileira (1992)

|July 24, 2024

概括

NAMPT rs2058539"CC"基因型与患非酒精性脂肪肝疾病的风险增加了2.5倍. 这种遗传变异可能是非酒精性脂肪肝疾病易感性的早期指标.

科学领域:

遗传学遗传学是一个
肝病学肝病学是一种肝病学.
代谢障碍代谢障碍代谢障碍

背景情况:

非酒精性脂肪肝 (NAFLD) 是一种普遍的慢性肝病,全球发病率不断增加.
由NAMPT基因编码的Visfatin在与NAFLD相关的代谢过程中发挥作用,包括胰岛素耐药性,肥胖,炎症和氧化应激.

研究的目的:

研究visfatin基因 (NAMPT) rs2058539中的特定变异与患非酒精性脂肪肝疾病的风险之间的关联.
探索visfatin基因多态化在NAFLD病理生理学中的潜在作用.

主要方法:

一项涉及312名参与者的病例控制研究 (154名有活检证明的NAFLD,158名对照).
使用PCR-RFLP方法进行了NAMPT rs2058539多态的基因定型.

主要成果:

在NAFLD患者和对照人群之间,NAMPT rs2058539基因型和等位基因的分布有显著差异.
与"AA"基因型相比",CC"基因型与NAFLD的风险增加了2.52倍 (OR=2.52,95%CI=1.36-4.37,p=0.034).
在NAFLD患者中,NAMPT rs2058539的"C"等位基因更频繁 (OR=1.77,95%CI=1.14-2.31,p=0.022).

结论:

NAMPT rs2058539"CC"基因型被确定为非酒精性脂肪肝疾病易感性增加的潜在遗传标志物.
需要在不同人群中进行进一步的研究来验证这些发现,并确认这种NAMPT变异在NAFLD中的作用.

更多相关视频

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells

Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells

Published on: July 18, 2019

相关概念视频

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Comparing Copy Number Variations and SNPs

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...